Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates

Early Human Development

Volumn 82, Issue 4, 2006, Pages 235-239

  Boutsikou, Theodora ^a   Malamitsi Puchner, Ariadne ^a   Economou, Emmanuel ^a   Boutsikou, Maria ^a   Puchner, Karl Philipp ^a   Hassiakos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Angiogenesis; Fetus; Intrauterine growth restriction; Neonate; Soluble vascular endothelial growth factor receptor 1

Indexed keywords

VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; FETUS; FETUS DISEASE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MALE; MOTHER; NEUROPATHOLOGY; NEWBORN; NEWBORN DISEASE; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE;

ADULT; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; FETUS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PROSPECTIVE STUDIES; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33646073060     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2005.09.010     Document Type: Article

References (47)

1. Liekens S., DeClercq E., and Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 61 (2001) 253-270
2. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146 (1995) 1029-1039
3. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18-32
4. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
5. Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 (1989) 1309-1312
6. de Vries C., Escobedo J.A., Ueno H., Houk K., Ferrara N., and Williams L.T. The fms like tyrosine kinase a receptor for vascular endothelial growth factor. Science 255 (1992) 989-991
7. Terman B.I., Dougher-Vermazen M., Carrion M.E., Dimitrov D., Gospodarowicz D.C., and Bohlen P. Identification of KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 187 (1992) 1579-1586
8. Millauer B., Wizigmann-Voos S., Schnurch H., et al. High affinity vascular endothelial growth factor binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
9. Barleon B., Siemeister G., Martiny-Baron G., Weindel K., Herzog C., and Marme D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57 (1997) 5421-5425
10. Pepper M.S., Mandriota S.J., Jeltsch M., Kumar V., and Alitalo K. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J Cell Physiol 177 (1998) 439-452
11. Sheibani N., and Frazier W.A. Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol Biol Cell 9 (1998) 701-713
12. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takahashi T., Neufeld G., et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9 (1994) 2683-2690
13. Kaipainen A., Korhonen J., Pajusola K., Aprelikova O., Persico M.G., Terman B.I., et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 178 (1993) 2077-2088
14. Barleon B., Hauser S., Schollmann C., Weindel K., Marme D., Yayon A., et al. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 54 (1994) 56-66
15. Kendall R.L., Wang G., DiSalvo J., and Thomas K.A. Specificity of vascular endothelial cell growth factor receptor ligand binding domains. Biochem Biophys Res Commun 201 (1994) 326-330
16. Olofsson B., Pajusola K., Kaipainen A., von Euler G., Joukov V., Saksela O., et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93 (1996) 2576-2581
17. Kendall R.L., and Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A 90 (1993) 10705-10709
18. Huang K., Andersson C., Roomans G.M., Ito N., and Claesson-Welsh L. Signaling properties of VEGF receptor-1 and-2 homo- and heterodimers. Int J Biochem Cell Biol 33 (2001) 315-324
19. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226 (1996) 324-328
20. Belgore F.M., Blann A.D., Li-Saw-Hee F.L., Beevers D.G., and Lip G.Y. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 87 A9 (2001) 805-807
21. Clark D.E., Smith S.K., He Y., Day K.A., Licence D.R., Corps A.N., et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 59 (1998) 1540-1548
22. Pollack R.N., and Divon M.Y. Intrauterine growth retardation: definition, classification and etiology. Clin Obstet Gynecol 35 (1992) 99-107
23. 2 diffusion and placental expression of PIGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction. J Physiol 550 (2003) 641-656
24. Regnault T.R.H., Galan H.L., Parker T.A., and Anthony R.V. Placental development in normal and compromised pregnancies-a review. Placenta 23 Suppl A (2002) S119-S129
25. Gardosi J., Chang A., Kaylan B., Sahota D., and Symonds E.M. Customised antenatal growth charts. Lancet 339 (1992) 283-287
26. Gardosi J., Mongelli M., Wilcox M., and Chang A. An adjustable fetal weight standard. Ultrasound Obstet Gynecol 6 (1995) 168-174
27. Barleon B., Reusch P., Totzke F., Herzog C., Keck C., Martiny-Baron G., et al. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors. Angiogenesis 4 (2001) 143-154
28. Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., and Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87 (1996) 3336-3343
29. Clauss M., Weich H., Breier G., Knies U., Rockl W., Waltenberger J., et al. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271 (1996) 17629-17634
30. Rajakumar A., Michael H.M., Rajakumar P.A., Shibata E., Hubel C.A., Karumanchi S.A., et al. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta 26 (2005) 563-573
31. Kingdom J., Huppertz B., Seaward G., and Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol 92 (2000) 35-43
32. Kingdom J.C., and Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 474 (1999) 259-275
33. Luttun A., and Carmeliet P. Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered?. J Clin Invest 111 (2003) 600-602
34. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
35. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
36. Ahmed A., Dunk C., Ahmad S., and Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen. Placenta 21 Suppl A (2000) S16-S24
37. Charnock-Jones D.S., and Burton G.J. Placental vascular morphogenesis. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 953-968
38. Ahmed A., Li X.F., Dunk C., Whittle M.J., Rushton D.I., and Rollason T. Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta. Growth Factors 12 (1995) 235-243
39. Kingdom J.C., and Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18 (1997) 613-621
40. Shibata E., Rajakumar A., Powers R.W., Larkin R.W., Gilmour C., Bodnar L.M., et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90 (2005) 4895-4903
41. Wolf M., Shah A., Lam C., Martinez A., Smirnakis K.V., and Epstein F.H. Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol 193 (2005) 16-22
42. Tsao P.N., Wei S.C., Su Y.N., Chou H.C., Chen C.Y., and Hsieh W.S. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers. Pediatrics 116 (2005) 468-472
43. Berse B., Brown L.F., Van de Water L., Dvorak H.F., and Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 3 (1992) 211-220
44. Malamitsi-Puchner A., Tziotis J., Protonotariou E., Xyni K., Sarandakou A., and Creatsas G. Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life. Pediatr Res 45 (1999) 877-880
45. Jackson J.R., Seed M.P., Kircher C.H., Willoughby D.A., and Winkler J.D. The codependence of angiogenesis and chronic inflammation. FASEB J 11 (1997) 457-465
46. Pepe G.J., Billiar R.B., Leavitt M.G., Zachos N.C., Gustafsson J.A., and Albrecht E.D. Expression of estrogen receptors alpha and beta in the baboon fetal ovary. Biol Reprod 66 (2002) 1054-1060
47. Zachos N.C., Billiar R.B., Albrecht E.D., and Pepe G.J. Developmental regulation of baboon fetal ovarian maturation by estrogen. Biol Reprod 67 (2002) 1148-1156